Intraoperative radiation therapy is just one of the many innovative treatment options available at CTCA. Benefits of this therapy include lower risk of reoccurrence and fewer side effects.
CTCA OverviewList of Brochures
Cancer Treatment Centers of America (CTCA) has added Intraoperative Radiation Therapy (IORT) to its state-of-the-art radiation therapy program. IORT allows patients with a variety of cancer types to receive a single, powerful dose of radiation directly to a tumor site during surgery. This innovative technique helps to reduce treatment times and minimize side effects.
With IORT, our radiation oncologists deliver highly concentrated beams of radiation directly to the tumor bed immediately after tumor removal. This significantly increases the dose of radiation that can be delivered, while also shielding the surrounding healthy tissues and organs.
By delivering the equivalent of several weeks of standard radiation therapy in a single dose and treatment session, IORT helps to improve comfort, convenience and quality of life.
Compared to post-operative radiation, treatment times with IORT are considerably shorter--a single one-minute treatment during surgery versus as many as 3-6 weeks. IORT also destroys microscopic tumor cells left behind by surgery, before the cells have a chance to divide or migrate to other areas of the body.
In addition, for patients who need to receive additional radiation therapy after surgery, IORT can be used as a "boost" to treat microscopic diseases and shorten treatment time. An IORT boost may be a treatment option for prostate, rectal and gynecologic cancer patients, among others.
This cutting edge radiation treatment is performed with the Novac7, a mobile linear accelerator. IORT has significant benefits including:
CTCA at Midwestern Regional Medical Center and Southwestern Regional Medical center are among only a handful of hospitals in the United States to offer IORT using Novac7.
© Rising Tide 2020